I'm going to take part in the . . . Group Of The 3rd China Biopharmaceutical Innovation Cooperation Conference!

Guide: The biopharmaceutical industry has attracted much attention, and the 3rd China Biopharmaceutical Innovation Cooperation Conference is about to open.
driven by social factors such as national policies, economic development, aging population and other comprehensive factors such as biopharmaceutical technology, China's biopharmaceutical industry is entering a new stage, entering a period of rapid development, and market capacity is steadily rising.
innovation model from closed to open, new drug declaration from the original re-approval to heavy supervision, research and development production is also gradually digitized, frequently appear new drugs listed, capital investment gradually rational, diversified.
the end of 2019, the biopharmaceutical industry is attracting more attention.
The 3rd China Biopharmaceutical Innovation Cooperation Conference 2020, sponsored by Shanghai Wanyi Medical, will be held on December 3-4, and will last for 2 days, bringing together 800-plus industry experts and inviting 50-plus authoritative lecturers to share cutting-edge technical information, interpret the latest industrial policies, and comprehensively link the multi-party platform for production, research and development.
Conference Agenda Heavy Guests Four Roundtable Discussion Interactive Roundtable Discussion 1: Next Generation Antibody Drug Exploration and Development Host: Maohua, Frost and Sullivan Partners Interactive Roundtable Discussion 2: Nucleic Acid Drug Research Status and Prospects Host: Li Jia, Managing Director of LANSA Investment Interactive Roundtable Discussion 3: Domestic Innovation Drug Internationalization Strategy: Licensein/Out, The Way Forward? (The discussion guest is full) Host: Wang Gang, Chief Scientist of the Greater China Division of Corey's Life Sciences and Pharmaceuticals Division Interactive Roundtable Discussion 4: Small Molecules Targeting Anti-Cancer Drug Development Strategies and Opportunities (The Discussion Guest Is Full) Host: Xu Jiaxuan, Henyep Managing Director of Securities, Vice President of the Research Institute, General Manager of the Center for Health and Consumer Research, chief analyst of the pharmaceutical industry strongly support the support unit media support for previous photos if there is sponsorship / exhibition demand, please contact: Mr. Xiao danielxiao@healife.com danielxiao@healife.com s8613917465409; Ms. Zhuwinniezhu@healife.comwinniezhu@healife 8618817502898philzhang@healife;.com:86 18017269345 For speaking/academic cooperation needs, please contact: Ms. He percyhe@healife.com For participation/media cooperation needs, please contact: Ms. ZhangShelleyzhang@healife.com.